Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Bifidobacterium bifidum Rosell-71

What does the research say about Bifidobacterium bifidum Rosell-71?

4 health outcomes synthesised

Bifidobacterium bifidum Rosell-71 is a probiotic strain studied for its effects on mental health and cognitive outcomes. Research syntheses covering 4 health outcomes—depressive symptoms, cognitive function, depression symptoms, and general mental health—show predominantly beneficial directions across 13 total study references. The strongest evidence, based on 4 papers, points to moderate benefits on depressive symptoms in adults with psychiatric or cognitive disorders, though the overall evidence strength is rated low due to small study counts and potential publication bias.

Strongest evidence: The most researched outcome is Improved Depressive Symptoms, with all 4 studies reporting beneficial effects of moderate size in adults with psychiatric and cognitive disorders. No consistent effective dose was identified across studies. A separate synthesis on Reduced Depression Symptoms (3 studies, all beneficial, moderate effect) included a 2025 meta-analysis showing a statistically significant reduction (p=0.03; SMD=-0.55), but the strain was always part of probiotic blends, not tested alone.

Mixed or weaker evidence: Evidence for Improved Cognitive Function (3 studies, all beneficial but only one statistically significant) and Improved Mental Health (3 review articles, all beneficial but small effects, none statistically significant) is weaker and indirect. In both cases, findings often came from studies of multi-strain probiotics or synbiotics, making it difficult to attribute effects specifically to Rosell-71. Evidence strength is rated low to very low for these outcomes.

Effective dose patterns: No consistent effective dose, form, or duration was reported across any of the 4 research syntheses. This is a major gap in the evidence.

Population insights: The strongest evidence focuses on adults with psychiatric or cognitive disorders (for depressive symptoms) and adults with depression or general adult samples (for depression symptoms). No pediatric or elderly-specific subanalyses were reported.

Notable caveats: (1) Evidence bases are small (3–4 studies per outcome). (2) Publication bias is likely—null results may be underrepresented. (3) Most studies used probiotic mixtures, not this strain alone. (4) No statistically significant findings were reported for cognitive function or general mental health outcomes. (5) All syntheses rely heavily on review articles rather than direct primary trials.

Frequently asked

  • What is Bifidobacterium bifidum Rosell-71 good for according to research?
    Research syntheses show that Bifidobacterium bifidum Rosell-71 has been studied for depressive symptoms, cognitive function, depression symptoms, and general mental health. Across all 4 outcomes, studies predominantly report beneficial effects, though evidence strength is low to very low due to small study counts and indirect data. The strongest evidence is for improving depressive symptoms (4 studies, moderate effect size).
  • What dose of Bifidobacterium bifidum Rosell-71 is typically used in studies?
    No consistent dose, form, or duration has been reported across the reviewed studies. The available research syntheses note that dose data were 'not consistently reported' or 'none reported' for every outcome. This means that an evidence-based dose cannot be identified from the current literature.
  • Who benefits most from Bifidobacterium bifidum Rosell-71?
    The population with the most consistent evidence is adults with psychiatric or cognitive disorders (for depressive symptoms) and adults with depression (for reduced depression symptoms). General adult populations also showed benefits in some studies, but specific demographic subanalyses (e.g., by age, sex, or baseline deficiency) are not available in the current evidence.
  • Does Bifidobacterium bifidum Rosell-71 help with cognitive function?
    All 3 included studies reported beneficial effects on cognitive function, but only one meta-analysis reached statistical significance (large effect, SMD -0.90, p=0.01). The evidence base is very small and indirect—most studies evaluated probiotics or synbiotics broadly, not Rosell-71 specifically. Effects were mixed in size (small to large), and no significant findings were reported in the remaining studies.
  • Are there caveats or limitations in the research on Bifidobacterium bifidum Rosell-71?
    Yes. Key limitations include: (1) small evidence bases (3–4 studies per outcome), (2) likely publication bias favoring positive results, (3) most studies tested the strain as part of a probiotic blend rather than alone, making it hard to attribute effects specifically, (4) no consistent dosing information, and (5) two outcomes (cognitive function, general mental health) had no statistically significant findings in the underlying studies. Conclusions should be considered preliminary.

Most-studied combinations with Bifidobacterium bifidum Rosell-71

most supplement research is combination research
Also studied with:Bifidobacterium breve Rosell-70 (6), Bifidobacterium longum Rosell-175 (3), Lactobacillus helveticus Rosell-52 (5), Lactobacillus plantarum Rosell-A (5), Lactobacillus acidophilus L-92 (2), Bifidobacterium plantarum (2)
    Back to top